Problems of diclofenac
Text created by automatic translator Elia and has not been subsequently revised by translators. Elia Elhuyar
Problems of diclofenac
01/11/2006 | Elhuyar
(Photo: Dhypharm)
Diclofenac is a conventional anti-inflammatory drug that is marketed, among others, with the commercial name of Volta. It has been used for decades, but now some Australian researchers are asking to review the drug because it increases the risk of heart disease.
The doubt has occurred after analyzing 23 published studies on this drug, which have analyzed a total of 1.6 million cases and which, according to the researchers, the risk of infarction or sudden death increases by 40%. Therefore, they ask that the security level of diclofenac be reviewed and, if necessary, withdraw from the market. On the other hand, this work considers that naproxen is a drug without danger, so it can replace diclofen.
1.
225 225 225
2006 2006 2006 2006 2006
Results Results Results
022 022
Pharmacology Pharmacology
News in brief brief
Information about information
Zu idazle
Zientzia aldizkaria
